Tolerability of Nausea and Vomiting and Associations With Weight Loss in a Randomized Trial of Liraglutide in Obese, non-Diabetic Adults
Based on Phase 3 trial data, Retatrutide appears to produce greater average weight loss than semaglutide (the active ingredient in Wegovy and Ozempic)
Rather than viewing telehealth platforms as competitors, clinicians can position themselves as partners in care
2011;34(Suppl 2):S26471
A: People who dislike needles, prefer simpler routines, travel frequently, or struggled with injectable adherence may prefer the pill format
La administracin perifrica de LIRA se sigue de su localizacin a nivel de los rganos circunventriculares y el ncleo arcuato hipotalmico, donde favorece la activacin de vas anorexignicas e inhibicin de las orexignicas, merced a la estimulacin de neuronas productoras de Pro-opiomelanocortina/Transcripto cocana-anfetamina (POMC/CART) y la inhibicin indirecta del eje orexiante NeuropptidoY/Protena relacionada con Agouti (NPY/AgRP) a travs de mecanismos gabargicos18